The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.

George, James N

George, James N.

Affiliation

George JN; Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. james-george@ouhsc.edu

Kidney Int Suppl ; (112): S52-4, 2009 Feb.

Article in En | MEDLINE | ID: mdl-19180137

Subject(s)

Hemolytic-Uremic Syndrome; Purpura, Thrombotic Thrombocytopenic; ADAM Proteins/blood; ADAM Proteins/deficiency; ADAMTS13 Protein; Biomarkers/blood; Cognition; Combined Modality Therapy; Diagnosis, Differential; Hemolytic-Uremic Syndrome/blood; Hemolytic-Uremic Syndrome/diagnosis; Hemolytic-Uremic Syndrome/mortality; Hemolytic-Uremic Syndrome/therapy; Humans; Immunosuppressive Agents/therapeutic use; Oklahoma/epidemiology; Plasma Exchange; Predictive Value of Tests; Purpura, Thrombotic Thrombocytopenic/blood; Purpura, Thrombotic Thrombocytopenic/diagnosis; Purpura, Thrombotic Thrombocytopenic/mortality; Purpura, Thrombotic Thrombocytopenic/therapy; Recurrence; Registries; Terminology as Topic; Time Factors; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Hemolytic-Uremic Syndrome Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Kidney Int Suppl Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google